Concept for a study design in patients with severe community-acquired pneumonia: A randomised controlled trial with a novel IGM-enriched immunoglobulin preparation – The CIGMA study
Tobias Welte(Medizinische Hochschule Hannover), Antoní Torres(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), Steven M. Opal(Brown University), Henning Ebelt(University Hospital in Halle), Andrea Wartenberg‐Demand(Biotest (Germany)), Miquel Ferrer(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), Kurt Löffler, Dorothee E. Schliephake(Biotest (Germany)), R. Phillip Dellinger(Cooper University Health Care), Karl Werdan(Universitäts-Herzzentrum Freiburg-Bad Krozingen)
Cited by 36
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Critical Care Medicine|2003|6k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Intensive Care Medicine|2003|2.9k